CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Edwards Lifesciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Edwards Lifesciences Corp
One Edwards Way
Phone: (949) 250-2500p:949 250-2500 IRVINE, CA  92614  United States Ticker: EWEW
Business Summary
Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Nicholas J.Valeriani 67 5/7/2024 11/13/2014
President, Chief Executive Officer Bernard J.Zovighian 56 5/11/2023 1/1/2016
Chief Financial Officer, Corporate Vice President Scott B.Ullem 57 1/2/2014 1/2/2014
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Valtech Cardio Ltd. 6 Yoni Netanyahu St' Or Yehuda Israel
Innovalve Bio Medical Ltd Sheba Medical Center Tel Hashomer Israel
Bmeye B.V. Academic Medical Center Meibergdreef 9 Amsterdam Netherlands
5 additional Subsidiary records available in full report.

Business Names
Business Name
CardiAQ Valve Technologies, Inc.
CAS Medical Systems Inc
Edwards Lifesciences (Japan) Inc.
5 additional Business Names available in full report.

General Information
Number of Employees: 19,800 (As of 12/31/2023)
Outstanding Shares: 589,800,000 (As of 9/30/2024)
Shareholders: 7,599
Stock Exchange: NYSE
Federal Tax Id: 364316614
Fax Number: (302) 655-5049
Email Address: investor_relations@edwards.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024